Form 8-K - Current report:
SEC Accession No. 0001903596-25-000211
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:48
Documents
13
Period of Report
2025-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 kays_8k.htm   iXBRL 8-K 25181
  Complete submission text file 0001903596-25-000211.txt   194375

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE kays-20250424.xsd EX-101.SCH 3026
3 XBRL LABEL FILE kays-20250424_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE kays-20250424_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT kays_8k_htm.xml XML 3471
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

EIN.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-177532 | Film No.: 25880272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)